Papers - OKAMOTO Teppei
-
Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community-Dwelling Population: A Four-Year Longitudinal Study.
Fukushima T, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Nakaji S, Hatakeyama S.
Lower Urinary Tract Symptoms 2026.7
-
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.
Sato H, Okamoto T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yamamoto H, Imai A, Murashita K, Nakaji S, Hatakeyama S.
Lower Urinary Tract Symptoms 2026.3
-
The long-term impact of mild COVID-19 on cardiovascular disease and mortality in patients on hemodialysis: a post-Omicron era retrospective observational study.
Okamoto A, Okamoto T, Ichiyama T, Fukushima T, Omizo S, Asanuma H, Sato H, Sakurai H, Yoneyama A, Yoneyama F, Ishii N, Oishi T, Tanaka R, Miura H, Hamaya T, Kodama H, Fujita N, Murasawa H, Yamamoto H, Imai A, Saitoh H, Hatakeyama S, Ohyama C, Suzuki T.
Renal Failure 2025.6
-
Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants
Hisashi Sakurai, Teppei Okamoto, Anna Yoneyama, Fumiya Yoneyama, Tomoko Hamaya, Hirotake Kodama, Naoki Fujita, Hayato Yamamoto, Kazuyuki Mori, Takeshi Fujita, Atushi Imai, Reiichi Murakami, Hirofumi Tomita,Shingo Hatakeyama, Chikara Ohyama
Clinical and Experimental Nephrology 2025.3
-
パイロット研究；抗癌剤治療を要する進行尿路上皮癌患者を対象とした人参養栄湯によるサルコペニア予防効果の検討（単施設、単群、非盲検化試験）
岡本 哲平
新薬と臨床 73 ( 8 ) 759 - 769 2024.8
-
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8
Kento Morozumi,Koji Mitsuzuka,Shintaro Narita,Masahiro Takahashi,Sadafumi Kawamura,Tatsuo Tochigi,Yoichi Arai,Senji Hoshi,Jiro Shimoda,Shigeto Ishidoya,Teppei Okamoto,Shingo Hatakeyama,Toshihiko Sakurai,Norihiko Tsuchiya,Chikara Ohyama,Tomonori Habuchi,Akihiro Ito
2022.1
-
The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan
Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C.
International Urology and Nephrology 2021.10
-
Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study
Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C.
Clinical and Experimental Nephrology 2021.9
-
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.
Shinohara M, Yamamoto H, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
International Journal of Urology 2026.3
-
Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study.
Tanaka R, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
International Journal of Urology 2026.1
-
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy.
Ishii N, Yoneyama T, Minakawa S, Konishi S, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S.
International Journal of Urology 2026.1
-
Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.
Oishi T, Yoneyama T, Miura Y, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S.
European Urology Open Science 2025.12
-
Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real-World Multicenter Study
Ishii N, Sekine Y, Shinohara M, Kawashima Y, Mori K, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Cancer Medicine 2025.9
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Sasaki D, Yoneyama T, Yoneyama F, Ozaki K, Ozaki Y, Miura Y, Fujita N, Okamoto T, Yamamoto H, Goto S, Yoshizawa T, Kurose A, Kijima H, Ohyama C, Hatakeyama S.
International Journal of Urology 2025.9
-
The Effects of the Blood-Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies.
Miura H, Hamaya T, Yoneyama T, Shimoyama T, Tsushima F, Togashi K, Miura Y, Yoneyama A, Sato H, Omizo S, Mori K, Kodama H, Fujita N, Okamoto T, Yamamoto H, Kakeda S, Ohyama C, Hatakeyama S.
Prostate 2025.8
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study.
Yoneyama F, Shinohara M, Kawashima Y, Yoneyama A, Ishii N, Oishi T, Tanaka R, Miura H, Kodama H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Ohyama C, Hatakeyama S.
International Journal of Urology 2025.8
-
Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma.
Fukushima T, Numakura K, Shinohara M, Kawashima Y, Sekine Y, Mori K, Kobayashi M, Asanuma H, Ichiyama T, Sakurai H, Ozaki K, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Scientific Reports 2025.7
-
Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population. Prostate.
Miura Y, Yoneyama T, Yamamoto H, Suzuki H, Otsubo T, Fujita E, Tsushima F, Goto S, Okamoto T, Fujita N, Ishiyama M, Yoshizawa T, Kakeda S, Hatakeyama S, Ohyama C.
Prostate 2025.3
-
Multicenter, international, retrospective study of prognostic factors for Ra223.
Oishi T, Luo HL, Hatayama Y, Kawaguchi H, Sasaki D, Tanaka R, Ishii N, Mikami J, Okamoto T, Yamamoto H, Aoki M, Su YL, Chen YH, Chang YH, Chen YT, Wang HJ, Ohyama C, Hatakeyama S.
Scientific Reports 2025.3
-
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
Kai Ozaki, Hayato Yamamoto, Yuya Sekine, Hirotaka Horiguchi, Shogo Hosogoe, Jotaro Mikami, Naoki Fujita, Noriko Tokui, Kazutaka Okita, Teppei Okamoto, Kanami Mori, Mizuki Kobayashi, Kazuyuki Numakura, Takahiro Yoneyama, Ryuji Tabata, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama
International Journal of Clinical Oncology 2025.3
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.
Ozaki K, Yamamoto H, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
International Journal of Urology 2025.3
-
Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report
Yoneyama F, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Hatakeyama S.
Urology Case Reports 2025.2
-
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
Taigo Kato, Junya Furukawa, Nobuyuki Hinata, Kosuke Ueda, Isao Hara, Fumiya Hongo, Ryuichi Mizuno, Teppei Okamoto, Hiroshi Okuno, Takayuki Ito, Masahiro Kajita, Mototsugu Oya, Yoshihiko Tomita, Nobuo Shinohara, Masatoshi Eto, Hirotsugu Uemura
International Journal of Clinical Oncology 2024.11
-
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy
International Journal of Urology 31 ( 12 ) 1330 - 1336 2024.8
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Mori K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C.
Scientific Reports 2023.9
-
Relationship between lower urinary tract symptoms and frailty
Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.4
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.3
-
Relationship between lower urinary tract symptoms and frailty
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.3
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Translational Andrology and Urology 2023.2
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C
Prostate 2023.2
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.1
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.
World Journal of Urology 2023.1
-
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Cancers 2022.12
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.
World Journal of Urology 2022.12
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Urologic Oncology: Seminars and Original Investigations 2022.12
-
Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.
2022.11
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.
Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Urologic Oncology: Seminars and Original Investigations 2022.10
-
Relationship between the cross-sectional area of the lumbar dural sac and lower urinary tract symptoms: A population-based cross-sectional study.
Oyama T, Wada K, Koyama K, Kumagai G, Tanaka S, Asari T, Imai A, Okamoto T, Hatakeyama S, Jung S, Sugimura Y, Ohyama C, Ishibashi Y.
PLOS ONE 2022.8
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
World J Mens Health. 2022.3
-
Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study
Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C.
2022.2
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Scientific Reports 2022.1
-
Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
2021.12
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
Scientific Reports 2021.11
-
Association between female urinary urgency and aponeurotic ptosis: Results from a community-based cross-sectional study in Japan.
Ozaki Y, Okamoto T, Miura Y, Iida K, Uemura N, Sugimura Y, Hatakeyama S, Urushidate S, Ohyama C
Neurourology and urodynamics 40 ( 6 ) 1678 - 1685 2021.8
-
Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
Okamoto T, Noro D, Hatakeyama S, Narita S, Mitsuzuka K, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Tanaka T, Kawaguchi T, Ishidoya S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
BMC cancer 21 ( 1 ) 605 2021.5
-
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.
Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C
Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.
Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
World journal of urology 2021.3
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021.3
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).
Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 39 ( 3 ) 191.e1 - 191.e8 2021.3
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3
-
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.
Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
BJU international 2021.1
-
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.
Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
World journal of urology 39 ( 1 ) 169 - 175 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021
-
RARCと回腸を利用した尿路変向術
米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人
Japanese Journal of Endourology 34 ( 1 ) 24 - 32 2021
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.
Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2020.12
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.
Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 2020.12
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 2020.12
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologia internationalis 1 - 8 2020.12
-
Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.
Okamoto T, Hatakeyama S, Togashi K, Hamaya T, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C
Clinical and experimental nephrology 24 ( 10 ) 955 - 962 2020.10
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.8
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, Osamu Soma, Itsuto Hamano, Toshikazu Tanaka, Hiromichi Iwamura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.8
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2020.8
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.
Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
International urology and nephrology 52 ( 8 ) 1421 - 1428 2020.8
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.8
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.8
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).
Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2020.7
-
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Itsuto Hamano, Teppei Okamoto, Koji Mitsuzuka, Akihiro Ito, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 7 ) 610 - 617 2020.7
-
Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
IJU case reports 3 ( 4 ) 141 - 144 2020.7
-
Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.
Hamano I, Hatakeyama S, Hamaya T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
IJU case reports 3 ( 4 ) 141 - 144 2020.7
-
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Hamano I, Okamoto T, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 7 ) 610 - 617 2020.7
-
Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis
Teppei Okamoto
Clinical and experimental nephrology 2020.6
-
The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan
Teppei Okamoto
Neurourology and Urodynamics 39 ( 5 ) 1567 - 1575 2020.5
-
Altered gut microbiome associated with overactive bladder and daily urinary urgency
Teppei Okamoto
World Journal of Urology 39 ( 3 ) 847 - 853 2020.5
-
Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.
Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
Lower urinary tract symptoms 12 ( 2 ) 128 - 136 2020.5
-
Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.
Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
Lower urinary tract symptoms 12 ( 2 ) 128 - 136 2020.5
-
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.
Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 4 ) 344 - 349 2020.4
-
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.
Okita K, Hatakeyama S, Imai A, Tanaka T, Hamano I, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Nakaji S, Suzuki T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 4 ) 344 - 349 2020.4
-
The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan
畠山真吾、今井篤 他
World Journal of Urology 2020.3
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan
畠山真吾、今井篤、他
International Urology and Nephrology 2020.3
-
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.
Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2
-
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.
Suppanuntaroek S, Hatakeyama S, Fujita N, Kubota Y, Suzuki Y, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Mori K, Imai A, Yoneyama T, Hashimoto Y, Ohyama C
International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2
-
ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績
米山 高弘, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人
Japanese Journal of Endourology 33 ( 2 ) 325 - 329 2020
-
Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single‐center, open‐label, prospective randomized study
畠山真吾、大山力 他
Therapeutic Apheresis and Dialysis 24 ( 5 ) 568 - 577 2019.12
-
Validation and development of the CHAARTED criteria in patients with hormone‐naïve metastatic prostate cancer: A multi‐institutional retrospective study in Japan
畠山真吾、大山力 他
International Journal of Urology 27 ( 1 ) 90 - 91 2019.10
-
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C
Medical oncology (Northwood, London, England) 36 ( 10 ) 88 2019.9
-
The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan
畠山真吾、今井篤 他
The Journal of Sexual Medicine 16 ( 12 ) 1922 - 1929 2019.9
-
Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.
Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C
World journal of urology 37 ( 9 ) 1827 - 1835 2019.9
-
Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.
Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
IJU case reports 2 ( 4 ) 236 - 239 2019.7
-
Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan
Teppei Okamoto
World Journal of Urology 2018.12
-
Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.
Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Koie T, Suzuki T, Ohyama C
Clinical and experimental nephrology 22 ( 5 ) 1174 - 1181 2018.10
-
Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study
Teppei Okamoto
International Urology and Nephrology 50 ( 9 ) 1713 - 1720 2018.9
-
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis
Teppei Okamoto
PLOS ONE 13 ( 7 ) e0199160 2018.7
-
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.
Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C
Oncotarget 9 ( 25 ) 17396 - 17405 2018.4
-
Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.
Teppei Okamoto
Clinical and experimental nephrology 2018.3
-
The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.
Teppei Okamoto
BMC nephrology 2018.3
-
The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.
Okamoto T, Hatakeyama S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M, Hosogoe S, Tanaka Y, Takashima T, Saitoh F, Suzuki T, Ohyama C
BMC nephrology 19 ( 1 ) 71 2018.3
-
The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.
Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C
PloS one 12 ( 7 ) e0182136 2017
-
Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C
PloS one 11 ( 5 ) e0153961 2016
-
Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.
Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto T, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Hakamada K
Case reports in oncology 7 ( 1 ) 233 - 8 2014.1
-
Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C
Transplantation 95 ( 3 ) 418 - 25 2013.2
-
Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer
HASHIMOTO Yasuhiro, IMANISHI Kengo, TOKUI Noriko, OKAMOTO Teppei, OKAMOTO Akiko, HATAKEYAMA Shingo, YONEYAMA Takahiro, KOIE Takuya, KAMIMURA Noritaka, OHYAMA Chikara
International journal of clinical oncology 18 ( 1 ) 177 - 182 2013.2
-
Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.
Hashimoto Y, Imanishi K, Tokui N, Okamoto T, Okamoto A, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C
International journal of clinical oncology 18 ( 1 ) 177 - 82 2013.2
-
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
Okamoto T, Yoneyama MS, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C, Tsuboi S
Molecular medicine reports 7 ( 2 ) 359 - 64 2013.2
-
[Adult mature teratoma of the testis: a case report].
Imanishi K, Hatakeyama S, Okamoto T, Suzuki Y, Sugiyama N, Yamamoto H, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C
Hinyokika kiyo. Acta urologica Japonica 59 ( 1 ) 57 - 60 2013.1
-
Blood Group Antigen Targeting Peptide Suppresses Thrombotic Microangiopathy in Renal Glomerular Capillaries after ABO-Incompatible Blood Reperfusion
Yoneyama Tohru, Hatakeyama Shingo, Ymamoto Hayato, Imanishi Kengo, Okamoto Teppei, Tokui Noriko, Sugiyama Naoki, Suzuki Yuichiro, Kudo Shigemasa, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Fukuda Michiko N., Ohyama Chikara
弘前医学 64 ( 0 ) S121 - 128 2013
-
[Metastatic renal tumor from oral floor cancer: a case report].
Ishibashi Y, Hatakeyama S, Okamoto T, Suzuki Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Sakaki H, Kobayashi W, Kimura H, Ohyama C
Hinyokika kiyo. Acta urologica Japonica 58 ( 11 ) 609 - 12 2012.11
-
[Adrenal pheochromocytoma with multiple neurofibromatosis on the trunk].
Tokui N, Okamoto T, Imanishi K, Sugiyama N, Suzuki Y, Ishimura H, Hatakeyama S, Kudoh S, Yoneyama T, Koie T, Kamimura N, Ohyama C
Hinyokika kiyo. Acta urologica Japonica 58 ( 1 ) 17 - 9 2012.1
-
Skin perfusion pressure is a prognostic factor in hemodialysis patients.
Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C
International journal of nephrology 2012 385274 2012
-
Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.
Hatakeyama S, Yamamoto H, Okamoto A, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C
International journal of nephrology 2012 376128 2012
-
Advancements in Urology 2011 : A Japanese Urological Association (JUA)/American Urological Association (AUA) Symposium
NAITO Seiji, EGAWA Shin, NAKAGAWA Masayuki, KAKEHI Yoshiyuki, FLANIGAN Robert C, HAYASHI Tetsutaro, OHARA Shinya, TEISHIMA Jun, SHOJI Koichi, SENTANI Kazuhiro, OUE Naohide, YASUI Wataru, MATSUBARA Akio, SAKAMOTO Shinichi, KAWAMURA Koji, IMAMOTO Takashi, NIHEI Naoki, KYPRIANOU Natasha, ICHIKAWA Tomohiko, HASHIMOTO Kohei, MASUMORI Naoya, TANAKA Toshiaki, KITAMURA Hiroshi, TSUKAMOTO Taiji, KIMURA Kyosuke, TSUKII Toyonori, KAMIHIRA Osanu, SASSA Naoto, KOMATSU Tomonori, HATTORI Ryohei, GOTOH Momokazu, SHIMIZU Shinjiro, JO Yoshimasa, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, MIYAJI Yoshiyuki, NAGAI Atsushi, TSUZUKI Shunsuke, KIDO Masahito, YAMAMOTO Toshihiro, MIKI Jun, KIMURA Takahiro, MIKI Kenta, AOKI Manabu, EGAWA Shin, NAKANISHI Juro, WADA Yoshihiro, TAKAHASHI Wataru, HONDA Jiro, ETO Masatoshi, KITAGAWA Yasuhide, SHIGEHARA Kazuyoshi, MIWA Sotaro, MIYAGI Toru, KADONO Yoshifumi, KONAKA Hiroyuki, MIZOKAMI Atsushi, NAMIKI Mikio, KATO Takuma, YANO Toshifumi, HIRAMA Hiromi, UETSUKI Hiotsugu, TSUNEMORI Hiroyuki, INUI Masashi, SUGIMOTO Mikio, KAKEHI Yoshiyuki, ICHIMATSU Keisuke, IIDA Hiroaki, MORII Akihiro, YASUDA Kenji, WATANABE Akihiko, NOZAKI Tetsuo, KOMIYA Akira, FUSE Hideki, MAKI Yoshio, KURUMA Hidetoshi, GUST Kilian, MATSUMOTO Hiroaki, ZOUBEIDI Amina, FAZLI Ladan, LODDICK Sarah, BROOKS Nigel, GLEAVE Martin, CHOI Han Y, PARK Jong W, PARK Seo Y, LEE Hyun M, JEON Seong S, SEO Seong I, PARK Byung K, HIRAI Kenichi, NOMURA Takeo, YAMASAKI Mutsushi, MATSUBARA Takanori, SATO Fuminori, MIMATA Hiromitsu, SENO Yasuyuki, KATO Masao, MITA Koji, NOMURA Takeo, HUANG Wen-Chin, CHUNG Leland WK, MIMATA Hiromitsu, MURAKAMI Masaya, MIKI Jun, KIMURA Takahiro, HATANO Takashi, EGAWA Shin, MATSUTA Yosuke, AKINO Hironobu, NAMIKI Mikio, FUSE Hideki, SUZUKI Kouji, YOKOYAMA Osamu, ONIZUKA Chie, KAMIMURA Toshio, NAGANO Masafumi, YAMAGUCHI Takanori, KAMOTO Toshiyuki, HASHIMOTO Jiro, TAKAHASHI Satoshi, UEHARA Teruhisa, KURIMURA Yuichiro, TSUKAMOTO Taiji, FUKUMOTO Kazuhiko, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, TORIMOTO Kazumasa, TAKAMI Takeshi, HIRAYAMA Akihide, KUWADA Masaomi, KAGEBAYASHI Yoriaki, SAMMA Shoji, FUJIMOTO Kiyohide, HIRAO Yoshihiko, ISHIURA Yoshiyuki, YAEGASHI Hiroshi, KOSHIDA Kiyoshi, MAEDA Yoshiko, SEKIGUCHI Yuki, SHITAMURA Takahiro, INOUE Katumi, NOSE Kiyotaka, KAMOTO Toshiyuki, HAYAMI Hiroshi, ENOKIDA Hideki, NAKAGAWA Masayuki, NAITO Seiji, MATSUMOTO Tetsuro, UOZUMI Jiro, MIMATA Hiromitsu, TAKEI Mineo, YOKOYAMA Teruhiko, FUKUMOTO Kazuhiko, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, KAMIMURA Noritaka, FUJITA Naoki, TOKUI Noriko, OKAMOTO Teppei, IMANISHI Kengo, SUGIYAMA Naoki, IMAI Atsushi, OHYAMA Chikara, YOSHINO Hirofumi, CHIYOMARU Takeshi, ENOKIDA Hideki, KAWAKAMI Kazumori, TATARANO Shuichi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, TATARANO Shuichi, CHIYOMARU Takeshi, KAWAKAMI Kazumori, ENOKIDA Hideki, YOSHINO Hirofumi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, SEGAWA Takehiko, TAKAHASHI Takeshi, MATSUMOTO Keiyu, SUMIYOSHI Takayuki, UTSUNOMIYA Noriaki, MUGURUMA Koei, KAWAKITA Mutsushi, IKEDA Hiroshi, NOMURA Masayoshi, SHOU Takehiko, ISHIKAWA Kaori, KASHIWAGI Eiji, DEJIMA Takashi, SANEFUJI Hayato, OKUMURA Kouji, YANAGISAWA Takafumi, MIKI Jun, ISHII Gen, BANDO Shigehiro, MIKI Kenta, EGAWA Shin, TANAKA Nobuyuki, KIKUCHI Eiji, MATSUMOTO Kazuhiro, MIYAJIMA Akira, NAKAGAWA Ken, OYA Mototsugu, ISHII Gen, MIKI Jun, TABATA Ryuji, KIMURA Takahiro, EGAWA Shin, KAWAMURA Koji, SAKAMOTO Shinichi, UTSUMI Takanobu, IMAMOTO Takashi, NIHEI Naoki, ICHIKAWA Tomohiko
International journal of urology 18 ( 5 ) 388 - 408 2011.5
-
Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.
Hatakeyama S, Toikawa T, Okamoto A, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Suzuki Y, Sugiyama N, Imai A, Hashimoto Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Saitoh H, Funyu T, Ohyama C
International journal of nephrology 2011 464735 2011
-
APP-039 日本人における限局性前立腺癌リスク分類の妥当性に関する検討(総会賞応募ポスター,第99回日本泌尿器科学会総会)
古家 琢也, 鈴木 裕一朗, 橋本 安弘, 大山 力, 得居 範子, 今西 賢吾, 岡本 哲平, 杉山 尚樹, 畠山 真吾, 工藤 茂将, 米山 高弘, 神村 典孝
日本泌尿器科学会雑誌 102 ( 2 ) 2011
-
OP-156 限局性前立腺癌のブラキ治療後排尿障害に対するα1ブロッカーの効果について(前立腺腫瘍/放射線治療1,一般演題口演,第99回日本泌尿器科学会総会)
神村 典孝, 米山 徹, 盛 和行, 大山 力, 岡本 哲平, 得居 範子, 杉山 尚樹, 鈴木 裕一朗, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也
日本泌尿器科学会雑誌 102 ( 2 ) 2011
-
OP-186 CRPCに対するDocetaxel,Prednisolone,Zoledronic acid療法の検討(前立腺腫瘍/薬物療法2,一般演題口演,第99回日本泌尿器科学会総会)
米山 高弘, 古家 琢也, 神村 典孝, 羽渕 友則, 大山 力, 岡本 哲平, 得居 範子, 鈴木 裕一朗, 杉山 尚樹, 米山 徹, 畠山 真吾, 工藤 茂将, 盛 和行
日本泌尿器科学会雑誌 102 ( 2 ) 2011
-
PP-318 前立腺全摘除術後の下部尿路機能評価 : 1年後の尿失禁の予測因子は何か(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)
杉山 尚樹, 神村 典孝, 大山 力, 今西 賢吾, 岡本 哲平, 得居 範子, 鈴木 裕一朗, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也
日本泌尿器科学会雑誌 102 ( 2 ) 2011
-
PP-390 ABO血液型抗原をマスクするペプチド配列のスクリーニング(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)
米山 徹, 盛 和行, 古家 琢也, 神村 典孝, 大山 力, 畠山 真吾, 今西 賢吾, 得居 範子, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 米山 高弘
日本泌尿器科学会雑誌 102 ( 2 ) 2011
-
[Ganglioneuroma with calcification mimicking adrenal tumor: a case report].
Okamoto T, Suzuki Y, Sugiyama N, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Oyama C
Hinyokika kiyo. Acta urologica Japonica 56 ( 11 ) 621 - 3 2010.11
-
PP-214 進行性上部尿路上皮癌に対するGemcitabine+Carboplatin療法の検討(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会)
米山 高弘, 古家 琢也, 神村 典孝, 大山 力, 今西 賢悟, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 盛 和行, 立和田 得志, 橋本 安弘
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
APP-092 回腸新膀胱における排尿機能の経時的変化 : 中長期成績における検討(発表・討論,総会賞応募ポスター,第98回日本泌尿器科学総会)
古家 琢也, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢悟, 鈴木 裕一朗, 杉山 尚樹, 工藤 茂将, 盛 和行, 米山 高弘, 橋本 安弘
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
OP-199 下部尿路症状と関連する液性因子の検討(Neurourology/臨床3,一般演題口演,第98回日本泌尿器科学会総会)
今井 篤, 古家 琢也, 吉川 和暁, 百瀬 昭志, 大山 力, 神村 典孝, 岡本 哲平, 鈴木 裕一朗, 杉山 尚樹, 立和田 得志, 工藤 茂将, 米山 高弘, 橋本 安弘
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
OP-476 腹腔鏡手術を行った原発性アルドステロン症における術後血圧の変化について(副腎・後腹膜,一般演題口演,第98回日本泌尿器科学会総会)
神村 典孝, 大山 力, 二川原 健, 崎原 哲, 須田 俊宏, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 立和田 得志, 工藤 茂将, 米山 高弘, 橋本 安弘, 古家 琢也
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
PP-065 筋層浸潤膀胱癌に対するゲムシタビン+カルボプラチンによる術前化学療法の有用性(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会)
鈴木 裕一朗, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢吾, 杉山 尚樹, 工藤 茂将, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
PP-067 Cisplatin-unfit進行性膀胱癌に対する3段階化学療法の経験(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会)
立和田 得志, 古家 琢也, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢悟, 鈴木 裕一朗, 杉山 尚樹, 工藤 茂, 盛 和行, 米山 高弘, 橋本 安弘
日本泌尿器科学会雑誌 101 ( 2 ) 2010
-
PP-175 High risk前立腺癌に対するLHRHアゴニスト+エストラムスチンのネオアジュバント療法に関するPhase II study(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会)
工藤 茂将, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢吾, 鈴木 裕一朗, 杉山 尚樹, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也
日本泌尿器科学会雑誌 101 ( 2 ) 2010